NEW YORK, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA INC, founded in 2007, is a community nonprofit in the Health Care sector that reported $6.2M in total revenue in fiscal year 2024. Revenue surged 43% from the prior year, signaling strong growth momentum.
THE DRUGS FOR NEGLECTED DISEASES INITIATIVE (DNDI), NORTH AMERICA SUPPORTS DNDI'S GLOBAL VISION AND MISSION TO DEVELOP NEW DRUGS, OR NEW FORMULATIONS OF EXISTING DRUGS FOR PATIENTS SUFFERING FROM THE MOST NEGLECTED DISEASES. ACTING IN THE PUBLIC INTEREST, DNDI BRIDGES EXISTING R&D GAPS IN ESSENTIAL DRUGS FOR THESE DISEASES BY INITIATING AND COORDINATING DRUG R&D PROJECTS IN COLLABORATION WITH THE INTERNATIONAL RESEARCH COMMUNITY, THE PUBLIC SECTOR, THE PHARMACEUTICAL INDUSTRY, AND OTHER PARTNERS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $6,221,917 | $4,350,936 | +0.4% |
| Expenses | $6,349,740 | $4,172,304 | +0.5% |
| Net Income | $-127,823 | $178,632 | -1.7% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| LUIS PIZARRO | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| MEENA AHAMED | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| AFRICA STEWART | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| BENNETT SHAPIRO | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| KRISTINA TORGESON | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| DARIN PORTNOY | CHAIR OF THE BOARD | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| SHING CHANG | SECRETARY | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| JOHN LAWRENCE | TREASURER | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| DELALI ATTIPOE | EXECUTIVE DIRECTOR | 40.00 |
Officer
|
$239,914 | $71,070 | $310,984 |
| RACHEL COHEN | SENIOR ADVISOR, GLOBAL POL | 40.00 |
Officer
|
$213,183 | $68,664 | $281,847 |
| ILAN MOSS | HEAD OF MEDIA AND CONTENT | 40.00 |
Highest
|
$156,476 | $13,940 | $170,416 |
| VISHAL GOYAL | SENIOR CLINICAL PROJECT AN | 40.00 |
Highest
|
$146,409 | $31,015 | $177,424 |
| SHIRLEY LEUNG | SENIOR HR BUSINESS PARTNER | 40.00 |
Highest
|
$106,712 | $44,282 | $150,994 |
| RON SYKES | SENIOR INDIVIDUAL GIVING MANAGER | 40.00 |
Highest
|
$123,284 | $28,363 | $151,647 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $6,221,917 | $6,349,740 | $2,501,704 | $-127,823 |
| 2023 | $4,350,936 | $4,172,304 | $1,819,761 | $178,632 |
| 2022 | $3,931,942 | $3,853,071 | $1,155,455 | $78,871 |
| 2021 | $4,153,290 | $3,993,581 | $1,372,645 | $159,709 |
| 2020 | $3,738,262 | $3,585,571 | $1,506,481 | $152,691 |
| 2019 | $4,627,274 | $4,593,537 | $1,352,194 | $33,737 |
| 2018 | $5,843,041 | $6,026,040 | $2,330,609 | $-182,999 |
Compare DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA INC with other nonprofits in New York and across the country.